Approval · Notice of Compliance 37162 · 2026
DYRUPEG: Notice of Compliance 37162
Issued January 6, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 37162
- Date
- January 6, 2026
- Company
- Curateq Biologics Private LimitedTelangana, Telangana, India
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Canadian reference product
- NEULASTA
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DYRUPEG | Not yet assigned | — |
Medicinal ingredients
- PEGFILGRASTIM 10 MG per ML